Therefore, mitochondrial function alteration and C3-implicated immune reaction/inflammation (complementary pathway activation is documented in Table 3) are likely to contribute at least partly to the hepatic steatosis in the current transgenic mice based on human NAFLD gene expression studies. Here, C3 is linked to metabolic dysfunction-associated steatotic liver disease.